Graham is trading at $73.67, down 5.05%, with no clearly reported company-specific announcement explaining the October 14, 2026 decline.
- Available coverage describes a broader pullback after early-October strength, not a confirmed new catalyst.
- Oppenheimer lowered its price target to $115 from $130 on October 8 and maintained an Outperform rating; this does not establish the cause of today's move.
- The supplied market snapshot shows mixed major indexes and does not confirm a broad-market explanation.